Top Section/Ad
Top Section/Ad
Most recent
Record fundraising in 2025 has left private lenders fighting for deals
Long seen as adversaries, banks and private credit lenders are getting used to working together
Fahy will also lead asset-based finance origination
Direct lending default rates tick higher amid notable distressed situations
More articles/Ad
More articles/Ad
More articles
-
German pharmaceutical company Cheplapharm Greifswald is in the market for a €95m Schuldschein which the family-owned firm will not grow beyond the launch size. -
The subdued US private placement (USPP) market could be set to for a rush of deals in September, enlivening what has been a quiet year, writes Robert Cooke.
-
BMW exceeded market expectations with an A$150m MTN on Wednesday, surprising dealers with the strength of demand it attracted.
-
Austrian construction firm Porr has completed an amended and extended €65m of Schuldscheine signed last year, securing tighter margins and longer tenors.
-
Teva completed the final leg of the bond financing for its acquisition of Allergan's generic drugs business on Thursday, issuing a Sfr1bn ($1bn) triple tranche Swiss franc deal.
-
Euro private placement volumes have fallen by as much as a third this year, facing tough competition from tightly priced bank loans and the Schuldschein market, which has produced its strongest ever first half this year. Silas Brown and Elly Whittaker report.
